NCT02880280

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism

Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin is Superior to Human Chorionic Gonadotropin in Therapeutic Efficacy in Adolescent Boys With Congenital Hypogonadotropic Hypogonadism

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: Beijing Children's Hospital · Academic / Other
• Sex: Male
• Age: 138 Months – 18 Years
• Healthy volunteers: Not accepted

Summary

Observe the therapeutic efficacy of human menopausal gonadotropin combining with human chorionic gonadotropin in adolescent boys with congenital hypogonadotropic hypogonadism.

Detailed description

Observe safety and efficacy of human menopausal gonadotropin and human chorionic gonadotropin treating congenital hypogonadotropic hypogonadism in teenagers; which as clinic recommendation, may provide clinical basis for establishing standard treatment guideline in the future. Establish technological process and follow-up precept for human menopausal gonadotropin and human chorionic gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers. And find safety and effective dose for teenagers.

Conditions

• Kallmann Syndrome
• Hypogonadotropic Hypogonadism

Interventions

Type	Name	Description
DRUG	Human Menopausal Gonadotropin	Human Menopausal Gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers
DRUG	Human Chorionic Gonadotropin	Human Chorionic Gonadotropin injection treating congenital hypogonadotropic hypogonadism in teenagers

Timeline

• Start date: 2016-08-01
• Primary completion: 2017-08-01
• Completion: 2018-12-01
• First posted: 2016-08-26
• Last updated: 2016-08-26

Locations

1 site across 1 country: China